2021-01-04  The #NMPA has approved conditional marketing authorization for Sinopharmâ€™s vaccine, a testament to its safety &amp; efficacy. #China will continue to work with other parties to promote equitable vaccine distribution &amp; contribute to the global fight against #COVID19.
